These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 7461250)

  • 21. Skin typing for assessment of skin cancer risk and acute response to UV-B and oral methoxsalen photochemotherapy.
    Stern RS; Momtaz K
    Arch Dermatol; 1984 Jul; 120(7):869-73. PubMed ID: 6732259
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 8-Methoxypsoralen-DNA adducts in patients treated with 8-methoxypsoralen and ultraviolet A light.
    Yang XY; Gasparro FP; DeLeo VA; Santella RM
    J Invest Dermatol; 1989 Jan; 92(1):59-63. PubMed ID: 2642513
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Time course of activity of topical 8-methoxypsoralen on palmoplantar skin.
    Konya J; Diffey BL; Hindson TC
    Br J Dermatol; 1992 Dec; 127(6):654-6. PubMed ID: 1476927
    [No Abstract]   [Full Text] [Related]  

  • 24. Toxic hepatitis from oral methoxsalen photochemotherapy (PUVA).
    Pariser DM; Wyles RJ
    J Am Acad Dermatol; 1980 Sep; 3(3):248-50. PubMed ID: 7451691
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Combination therapy of oral methoxypsoralen: photochemotherapy (PUVA) and an aromatic retinoid (etretinate, tigason) in the treatment of psoriasis.
    Thirumoorthy T; Tham SN; Tan YC
    J Dermatol; 1986 Apr; 13(2):132-6. PubMed ID: 3531270
    [No Abstract]   [Full Text] [Related]  

  • 26. [Local supplementary administration in PUVA therapy of psoriasis].
    Meffert H; Metz D
    Dermatol Monatsschr; 1981 Dec; 167(12):766-8. PubMed ID: 7343342
    [No Abstract]   [Full Text] [Related]  

  • 27. Photochemotherapy of psoriasis with oral methoxsalen and longwave ultraviolet light.
    Parrish JA; Fitzpatrick TB; Tanenbaum L; Pathak MA
    N Engl J Med; 1974 Dec; 291(23):1207-11. PubMed ID: 4422691
    [No Abstract]   [Full Text] [Related]  

  • 28. Comparison of serum levels and clinical results of PUVA therapy with three different dosage forms of 8-methoxypsoralen.
    Siddiqui AH; Stolk LM; Cormane RH
    Arch Dermatol Res; 1984; 276(5):343-5. PubMed ID: 6486881
    [No Abstract]   [Full Text] [Related]  

  • 29. [Deposition of 3H-8-MOP in the eye and skin by PUVA therapy].
    Grüntzig J; Hölzle E; Holtemeyer H; von Wangenheim KH
    Fortschr Ophthalmol; 1985; 82(3):228-30. PubMed ID: 4029839
    [No Abstract]   [Full Text] [Related]  

  • 30. Photochemotherapy and the eye: photoprotective factors.
    Glew WB; McKeever G; Roberts WP; Malinin G; Nigra TP
    Trans Am Ophthalmol Soc; 1980; 78():243-54. PubMed ID: 7257058
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Experience in the photochemotherapy of psoriasis with rectal administration of the photosensitizer].
    Shinskiĭ GE; Bazhina NR
    Vestn Dermatol Venerol; 1989; (1):72-5. PubMed ID: 2718624
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 5-Methoxy psoralen, etretinate, and UVA for psoriasis.
    Lane-Brown M
    Int J Dermatol; 1987 Dec; 26(10):655-9. PubMed ID: 3429102
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [PUVA therapy of psoriasis in the light of histological and histochemical studies].
    Sarankiewicz-Konopka B; Placek W
    Przegl Dermatol; 1982; 69(1-2):25-31. PubMed ID: 7178487
    [No Abstract]   [Full Text] [Related]  

  • 34. Lack of dermal changes in uninvolved skin after photochemotherapy of psoriasis: biochemical studies.
    Blumenkrantz N; Weismann K; Asboe-Hansen G
    Acta Derm Venereol; 1979; 59(2):149-51. PubMed ID: 84493
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Psoralen cream plus ultraviolet A photochemotherapy (PUVA cream): our experience.
    Pozo-Román T; González-López A; Velasco-Vaquero ME; Núñez-Cabezón M
    J Eur Acad Dermatol Venereol; 2006 Feb; 20(2):136-42. PubMed ID: 16441619
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Photochemotherapy of psoriasis with oral 8-methoxypsoralen (author's transl)].
    Kukita A; Sakuma M; Tamaki K; Seiji M; Miura T; Torinuki W; Toda K; Imura M
    Nihon Hifuka Gakkai Zasshi; 1978 May; 88(6):383-8. PubMed ID: 307623
    [No Abstract]   [Full Text] [Related]  

  • 37. Bioavailability study of two different 8-methoxypsoralen (8-MOP) preparations in patients receiving PUVA therapy.
    Nørgaard M; Hueg B; Staberg B
    Photodermatol; 1985 Aug; 2(4):252-6. PubMed ID: 3903679
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Photochemotherapy with 8-methoxypsoralen and UVA. III. Fluorescent microscopy studies of binding and transport of 8-MOP in the human skin].
    Meffert H; Varthelmes H; Metz D; Sönnichsen N
    Dermatol Monatsschr; 1977 Aug; 163(8):619-27. PubMed ID: 913739
    [No Abstract]   [Full Text] [Related]  

  • 39. Serum levels of 8-methoxypsoralen in two different drug preparations: correlation with photosensitivity and UV-A dose requirements for photochemotherapy.
    Hönigsmann H; Jaschke E; Nitsche V; Brenner W; Rauschmeier W; Wolff K
    J Invest Dermatol; 1982 Oct; 79(4):233-6. PubMed ID: 7130741
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The importance of patient selection for photochemotherapy in psoriasis.
    DesGroseilliers JP; Reilly SM; Cullen AE
    Can Med Assoc J; 1981 Apr; 124(8):1016-8. PubMed ID: 7260785
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.